| Interleukins in cancer: from biology to therapy D Briukhovetska, J Dörr, S Endres, P Libby, CA Dinarello, S Kobold Nature Reviews Cancer 21 (8), 481-499, 2021 | 433 | 2021 |
| Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis X Liu, J Li, BL Cadilha, A Markota, C Voigt, Z Huang, PP Lin, DD Wang, ... Science advances 5 (6), eaav4275, 2019 | 184 | 2019 |
| Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse KM Quell, CM Karsten, A Kordowski, LN Almeida, D Briukhovetska, ... The Journal of Immunology 199 (2), 688-706, 2017 | 75 | 2017 |
| Monitoring C5aR2 expression using a floxed tdTomato-C5aR2 knock-in mouse CM Karsten, AV Wiese, F Mey, J Figge, TM Woodruff, T Reuter, O Scurtu, ... The Journal of Immunology 199 (9), 3234-3248, 2017 | 51 | 2017 |
| Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice B Spix, ES Butz, CC Chen, AS Rosato, R Tang, A Jeridi, V Kudrina, ... Nature communications 13 (1), 318, 2022 | 40 | 2022 |
| Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia A Gottschlich, M Thomas, R Grünmeier, S Lesch, L Rohrbacher, V Igl, ... Nature biotechnology 41 (11), 1618-1632, 2023 | 30 | 2023 |
| T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis D Briukhovetska, J Suarez-Gosalvez, C Voigt, A Markota, AD Giannou, ... Immunity 56 (1), 143-161. e11, 2023 | 29 | 2023 |
| Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22 AD Giannou, J Kempski, AM Shiri, J Lücke, T Zhang, L Zhao, DE Zazara, ... Immunity 56 (1), 125-142. e12, 2023 | 27 | 2023 |
| Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function M Seifert, MR Benmebarek, D Briukhovetska, F Märkl, J Dörr, BL Cadilha, ... British Journal of Cancer 127 (12), 2175-2185, 2022 | 15 | 2022 |
| C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection D Briukhovetska, B Ohm, FT Mey, J Aliberti, M Kleingarn, M Huber-Lang, ... Frontiers in Immunology 11, 1397, 2020 | 12 | 2020 |
| PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells SB Lacher, J Dörr, GP de Almeida, J Hönninger, F Bayerl, A Hirschberger, ... Nature, 1-9, 2024 | 3 | 2024 |
| Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy T Lorenzini, BL Cadilha, H Obeck, MR Benmebarek, F Märkl, ... British Journal of Cancer 129 (4), 696-705, 2023 | 3 | 2023 |
| Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma F Märkl, MR Benmebarek, J Keyl, BL Cadilha, M Geiger, C Karches, ... Journal for ImmunoTherapy of Cancer 11 (5), 2023 | 3 | 2023 |
| Flow cytometry detection and quantification of CAR T cells into solid tumors NJA Tokarew, JS Gosálvez, A Nottebrock, D Briukhovestka, S Endres, ... Methods in Cell Biology 167, 99-122, 2022 | 2 | 2022 |
| Defining C3aR expression in myeloid and lymphoid cells using a novel Td-Tomato-C3aR reporter knockin mouse Y Laumonnier, CM Karsten, A Czabanska, I Schmudde, D Briukhovetska, ... Immunobiology 10 (221), 1180, 2016 | 1 | 2016 |
| P09. 01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression ME Kirmaier, BL Cadilha, A Hadzic, W Schmitz, MR Benmebarek, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 1), 2024 | | 2024 |
| 10.01 Prostanoid-insensitive chimeric antigen receptor modified T cells mediate therapeutic efficacy in solid cancer models J Dörr, L Gregor, SB Lacher, A Öner, S Lesch, S Michaelides, L Majed, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 1), 2024 | | 2024 |
| Single sequencing-based development of chimeric antigen receptor (CAR) T cells for the treatment of acute myeloid leukemias A Gottschlich, M Thomas, R Grunmeier, S Lesch, LIV Rohrbacher, ... ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 2), 170-170, 2022 | | 2022 |
| P09. 03 Activation of IL-22 signaling correlates with higher CD155 expression and stratifies poor outcomes of early-stage lung and breast cancer patients D Briukhovetska, J Jobst, S Endres, S Kobold Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
| 09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma M Benmebarek, F Märkl, J Keyl, B Cadilha, M Geiger, C Karches, H Obeck, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
